About
P&F Cares
Innovating for a future of precision-focused patient recovery
"P&F CARES stands for
my English name,
‘Paul’, and ‘Friends’."
Leadership statement
A Vision for Better
Recovery
At P&F Cares, we believe that the journey to recovery should be as precise as the diagnosis itself.
Our commitment to improving quality of life through localized drug delivery technology is driven by
a singular focus: the patient.
Through the development of Voferon, we have redefined the possibilities of molecular stability. Our platform doesn't just deliver medicine; it manages the therapeutic environment, ensuring that high-
concentration treatments remain effective exactly where and when they are needed most.
Our heritage in clinical innovation ensures that every breakthrough we achieve is built on a foundation
of rigorous science and unyielding medical ethics.
Choi, Min Yong
CEO
OUR FOUNDATION
The Pillars of Clinical Excellence
Expertise
Led by world-class pharmacologists and clinicians,
we bridge the gap between complex research and
accessible patient solutions.
Put Patient First
Every technological leap is measured by its impact on
recovery times, pain management, and long-term
quality of life.
Precision
Micro-targeted delivery systems that ensure molecular
stability and pinpoint therapeutic accuracy across all
clinical applications.
Legacy of Innovation
The Heritage of P&F Cares
2025
Voferon Seoul St. Mary's Hospital Clinical trials completed
2026
Corporate Research Institute Certification, Venture Certification
2025
Voferon Seoul St. Mary's Hospital Clinical trials completed
2026
Corporate Research Institute Certification, Venture Certification
2014
Vygon contract
2015
Start Anesthesiology Product Registration
2016
Anesthesiology Product Launching
2017
Wooyoung Medical Partnership Distributor Agreement for Anticancer Pumps
2018
Newborn PICC Enrollment Begins, Oncology Pump Sales Begin, Vygon Platinum Distributor Awarded
2019
Newborn PICC Launching
2020
Arterial Line Launching, Midline Launching
2021
Additional registration of newborn products
2022
Vascular Access Product Registration
2023
Launching Vascular
Access products
2024
Opening of Bundang Yuldong Park Headquarters, Achieved 47% Annual Sales Growth Rate
OPERATIONAL FRAMEWORK
Our Organization
A systematic, architectural structure built for stability and clinical excellence,
ensuring every department serves our core mission of patient care.
RA
Regulatory Affairs & Clinical
Compliance
R&D
Molecular Research & Delivery
Development
Marketing & Sales
DOMESTIC / OVERSEAS
Global Market Expansion & Outreach
Production
High-Fidelity Pharmaceutical
Manufacturing
Management Support
Operational Strategy & Institutional
Governance
SCM
Global Supply Chain & Logistics
Management
Finance
Strategic Financial Planning &
Analysis
Design
Creative design &
Brand Management
A Global Vision for Innovation
Expanding access to innovative medical solutions worldwide. Our mission transcends borders
as we partner with global healthcare providers to implement life-changing drug delivery technologies.
150k+
PATIENTS REACHED
12
PATENTED PLATFORMS
24+
CLINICAL SITES